EventsThe 3rd International Online Conference on Biomimetics
Published
This submission belongs to the session S2. Biomimetic Materials—Structures, Surfaces and Interfaces of the event The 3rd International Online Conference on Biomimetics
Published date
19 Nov, 2026
Academic Editor
author-avatarYongmei Zheng
Citation
Jun-Hyeog Jang, kyeongho ju, A Plant-Derived Polydeoxyribonucleotide from Brassica rapa: A Sustainable Biomimetic of Salmon-Derived PDRN for Cutaneous Regeneration and Metabolic Modulation, in Proceedings of The 3rd International Online Conference on Biomimetics, 24 November–26 November 2026, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

A Plant-Derived Polydeoxyribonucleotide from Brassica rapa: A Sustainable Biomimetic of Salmon-Derived PDRN for Cutaneous Regeneration and Metabolic Modulation

image
kyeongho ju 1
1. Biochemistry, Inha university, Incheon, 22003, South Korea
Abstract

Polydeoxyribonucleotide (PDRN), a low molecular weight DNA mixture (50–1500 bp) conventionally purified from salmon trout (Oncorhynchus mykiss) sperm, is a clinically established tissue regenerative agent acting through adenosine A2A receptor activation and the nucleotide salvage pathway. Its exclusive reliance on animal tissue, however, imposes ethical, supply-chain, and immunogenicity constraints, motivating the search for a biomimetic alternative that reproduces its molecular architecture and bioactivity from a non-animal source. Here we extracted, characterized, and biologically evaluated a plant-derived PDRN from Brassica rapa (BR-PDRN), prepared using a modified CTAB extraction protocol coupled with controlled sonication to replicate the fragment-size profile of clinical-grade PDRN. Spectrophotometric quality control (A260/A280 = 1.95–2.05) and agarose gel electrophoresis confirmed high-purity DNA fragmented to 50–1000 bp, matching salmon-derived PDRN specifications. In NIH3T3 fibroblasts, BR-PDRN (50 µg/mL) significantly increased viability over 3–5 days, accelerated scratch wound closure at 48 h (p < 0.001), and upregulated the wound-healing growth factors VEGF, PDGF-b, KGF, and EGF. In HaCaT keratinocytes, BR-PDRN promoted proliferation and scratch closure at least as effectively as salmon-derived PDRN, with significantly superior late-phase proliferation. By engaging both dermal and epidermal compartments of cutaneous repair, BR-PDRN reproduces—and in the epithelial compartment exceeds—the regenerative activity of its animal-derived counterpart. In differentiated adipocytes, BR-PDRN and salmon-derived PDRN both significantly attenuated adiponectin and leptin secretion, comparably to the anti-obesity agent orlistat, indicating a shared, broader role for PDRN in adipocyte metabolic regulation. Together, these findings establish BR-PDRN as a structurally and functionally biomimetic, scalable, and ethically advantageous alternative to animal-derived PDRN for wound-healing and metabolic applications, exemplifying how plant biosynthetic machinery can be harnessed to recapitulate a clinically validated animal-derived biomaterial.

Keywords
Polydeoxyribonucleotide
Brassica rapa
Wound healing
Fibroblast
Keratinocyte
Engineering Bio-Inspired Abdominal Sutures: Exploring Novel Fibers with Hagfish Proteins and Spider Silk
Structural model of a biomimetic iron-porphyrin catalyst supported on Al₂O₃